TY - JOUR
T1 - Crystal 'unengineering'
T2 - reducing the crystallisability of sulfolobus solfataricus Hjc
AU - Middleton, Claire L.
AU - Parker, Joanne L.
AU - Knott, Gavin J.
AU - White, Malcolm F.
AU - Bond, Charles S.
PY - 2014/8/18
Y1 - 2014/8/18
N2 - The protein Hjc from the thermophilic archaeon Sulfolobus solfataricus (Ss) presented many challenges to both structure solution and formation of stable complexes with its substrate, the DNA four-way or Holliday junction. As the challenges were caused by an uncharacteristically high propensity for rapid and promiscuous crystallisation, we investigated the molecular cause of this behaviour, corrected it by mutagenesis, and solved the X-ray crystal structures of the two mutants. An active site mutant SsHjcA32A crystallised in space group I23 (a 144.2Å; 68% solvent), and a deletion of a key crystal contact site, SsHjcδ62-63 crystallised in space group P21 (a 64.60, b 61.83, c 55.25Å; β≤95.74°; 28% solvent). Characterisation and comparative analysis of the structures are presented along with discussion of the pitfalls of the use of protein engineering to alter crystallisability while maintaining biological function.
AB - The protein Hjc from the thermophilic archaeon Sulfolobus solfataricus (Ss) presented many challenges to both structure solution and formation of stable complexes with its substrate, the DNA four-way or Holliday junction. As the challenges were caused by an uncharacteristically high propensity for rapid and promiscuous crystallisation, we investigated the molecular cause of this behaviour, corrected it by mutagenesis, and solved the X-ray crystal structures of the two mutants. An active site mutant SsHjcA32A crystallised in space group I23 (a 144.2Å; 68% solvent), and a deletion of a key crystal contact site, SsHjcδ62-63 crystallised in space group P21 (a 64.60, b 61.83, c 55.25Å; β≤95.74°; 28% solvent). Characterisation and comparative analysis of the structures are presented along with discussion of the pitfalls of the use of protein engineering to alter crystallisability while maintaining biological function.
UR - http://www.scopus.com/inward/record.url?scp=84915820156&partnerID=8YFLogxK
U2 - 10.1071/CH14342
DO - 10.1071/CH14342
M3 - Article
AN - SCOPUS:84915820156
SN - 0004-9425
VL - 67
SP - 1818
EP - 1823
JO - Australian Journal of Chemistry
JF - Australian Journal of Chemistry
IS - 12
ER -